Success Metrics

Active Trials
7(88%)

Phase Distribution

Ph phase_2
7
88%
Ph phase_3
1
13%

Phase Distribution

0

Early Stage

7

Mid Stage

1

Late Stage

Phase Distribution8 total trials
Phase 2Efficacy & side effects
7(87.5%)
Phase 3Large-scale testing
1(12.5%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

0.0%

0 of 0 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

7

trials recruiting

Total Trials

8

all time

Status Distribution
Active(8)

Detailed Status

Recruiting6
Active, not recruiting1
Enrolling by invitation1

Development Timeline

Analytics

Development Status

Total Trials
8
Active
7
Success Rate
N/A
Most Advanced
Phase 3

Trials by Phase

Phase 27 (87.5%)
Phase 31 (12.5%)

Trials by Status

recruiting675%
active_not_recruiting113%
enrolling_by_invitation113%

Recent Activity

7 active trials
Showing 5 of 8
enrolling_by_invitationphase_2

A Long-Term Extension Study of IMVT-1402 in Adult Participants With Graves' Disease (GD)

NCT07286006
active_not_recruitingphase_2

A Study to Evaluate the Efficacy, Safety, and Tolerability of IMVT-1402 in Adult Participants With Active, Difficult to Treat Rheumatoid Arthritis

NCT06754462
recruitingphase_2

Efficacy and Safety of IMVT-1402 in Adult Participants With Primary Sjogren's Disease With Moderate to Severe Systemic Disease Activity

NCT06979531
recruitingphase_2

A Study to Assess the Efficacy, Safety, and Tolerability of IMVT-1402 as Treatment for Adult Participants With Graves' Disease

NCT07018323
recruitingphase_2

IMVT-1402 in Adult Participants With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)

NCT07032662
View all 8 trials

Clinical Trials (8)

Showing 8 of 8 trials
NCT07286006Phase 2

A Long-Term Extension Study of IMVT-1402 in Adult Participants With Graves' Disease (GD)

Enrolling By Invitation
NCT06754462Phase 2

A Study to Evaluate the Efficacy, Safety, and Tolerability of IMVT-1402 in Adult Participants With Active, Difficult to Treat Rheumatoid Arthritis

Active Not Recruiting
NCT06979531Phase 2

Efficacy and Safety of IMVT-1402 in Adult Participants With Primary Sjogren's Disease With Moderate to Severe Systemic Disease Activity

Recruiting
NCT07018323Phase 2

A Study to Assess the Efficacy, Safety, and Tolerability of IMVT-1402 as Treatment for Adult Participants With Graves' Disease

Recruiting
NCT07032662Phase 2

IMVT-1402 in Adult Participants With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)

Recruiting
NCT06727604Phase 2

A Study to Assess the Efficacy, Safety, and Tolerability of IMVT-1402 as Treatment for Adult Participants With Graves' Disease

Recruiting
NCT07039916Phase 3

Study to Assess the Efficacy and Safety of IMVT-1402 in Participants With Mild to Severe Generalized Myasthenia Gravis

Recruiting
NCT06980805Phase 2

A Study to Assess the Safety, Tolerability, and Efficacy of IMVT-1402 in Participants With Cutaneous Lupus Erythematosus (CLE)

Recruiting

All 8 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
8